BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 20, 2012
View Archived Issues
Novartis reports novel CDK9 inhibitors
Read More
First prenatal replacement therapy presented for rare form of dystonia
Read More
Biotherapy demonstrates activity relevant to multiple sclerosis
Read More
New in vivo data disclosed on monomethylfumarate prodrug for MS
Read More
ETS-2101 trial in brain cancer begins enrollment
Read More
German group discloses new agents for dermatological disorders
Read More
Novel products for tuberculosis designed at Sanofi
Read More
AstraZeneca stops AZD-2820 study
Read More
Novel agents for AIDS prepared at Pfizer
Read More
Canadian study investigates microglial activation in patients with PD
Read More
Phase III crizotinib study meets endpoint
Read More
NewLink updates enrollment information for algenpantucel-L trial
Read More
Galaxy Biotech regains worldwide rights to antibody for cancer
Read More
Zalicus completes phase I study of Z-944
Read More
Novelos reports imaging results with [124I]-CLR-1404 in brain cancer
Read More
Investigational gene therapy gets orphan drug status for adrenoleukodystrophy
Read More
Jenrin Discovery develops new agents targeting CB1 receptor
Read More
AstraZeneca and Rigel sign worldwide licensing agreement for asthma drug
Read More
French center synthesizes new agents for bone disorders
Read More
Team in Israel patents new treatments for genetic disorders
Read More
Vaxin receives phase I SBIR grant to support development of anthrax vaccine
Read More
Wellcome Trust supports development of nontyphoidal Salmonella conjugate vaccine
Read More
EMA validates MAAs for fixed-dose combination diabetes therapies
Read More
First clinical data disclosed on Genzyme DNA topoisomerase I inhibitor
Read More
EpiCept sells European rights for Ceplene to Meda
Read More
Viamet and NIAID enter agreement to advance new class of broad-spectrum antifungals
Read More
Novel candidate hepatitis therapies divulged by Gilead Sciences
Read More
Heptares and U.K. Medical Research Council extend collaboration
Read More